Truncated LHRH formulations

Details for Australian Patent Application No. 2005282231 (hide)

Owner The Council of the Queensland Institute of Medical Research (QIMR)

Inventors Zeng, Weiguang; Jackson, David Charles; Walker, John

Agent Davies Collison Cave

Pub. Number AU-B-2005282231

PCT Pub. Number WO2006/026834

Priority 2004905194 10.09.04 AU

Filing date 12 September 2005

Wipo publication date 16 March 2006

Acceptance publication date 10 March 2011

International Classifications

C07K 14/59 (2006.01) Peptides having more than 20 amino acids

A61K 38/24 (2006.01) Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

A61P 15/16 (2006.01) Drugs for genital or sexual disorders

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/026834 Priority application(s): WO2006/026834

10 March 2011 Application Accepted

  Published as AU-B-2005282231

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282232-Device and method to prevent culture media degradation

2005282229-Enzyme inhibitors and uses thereof